Sources | Names Used |
---|---|
CTRPv2 | BRD9876:MK-1775 (4:1 mol/mol) |
PharmacoGx | BRD9876:MK-1775 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | USP49 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.04 |
mRNA | DPY19L3 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.04 |
mRNA | ZNF140 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.04 |
mRNA | MAGEA2 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |
mRNA | PXN | CTRPv2 | pan-cancer | AAC | -0.25 | 0.04 |
mRNA | ZNF143 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |
mRNA | LRP5L | CTRPv2 | pan-cancer | AAC | 0.26 | 0.04 |
mRNA | HIBADH | CTRPv2 | pan-cancer | AAC | -0.24 | 0.04 |
mRNA | AHR | CTRPv2 | pan-cancer | AAC | -0.27 | 0.04 |
mRNA | ATP6V1G2-DDX39B | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |